Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD

Purpose Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in patients with COPD have not been reported. We hypothesized that the PA:A ratio correlated with EID and that results of the 6-minute walk test (6MWT) would be useful for predicting the risk associated with PA:A >1. Patients and methods We retrospectively measured lung function, 6MWT, emphysema area, and PA enlargement on CT in 64 patients with COPD. The patients were classified into groups with PA:A ≤1 and >1. Receiver-operating characteristic curves were used to determine the threshold values with the best cutoff points to predict patients with PA:A >1. Results The PA:A >1 group had lower forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1:FVC ratio, diffusion capacity of lung carbon monoxide, 6MW distance, and baseline peripheral oxygen saturation (SpO2), lowest SpO2, highest modified Borg scale results, percentage low-attenuation area, and history of acute COPD exacerbations ≤1 year, and worse BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise) index results (P<0.05). Predicted PA:A >1 was determined for SpO2 during 6MWT (best cutoff point 89%, area under the curve 0.94, 95% confidence interval 0.88–1). SpO2 <90% during 6MWT showed a sensitivity of 93.1, specificity of 94.3, positive predictive value of 93.1, negative predictive value of 94.3, positive likelihood ratio of 16.2, and negative likelihood ratio of 0.07. Conclusion Lowest SpO2 during 6MWT may predict CT-measured PA:A, and lowest SpO2 <89% during 6MWT is excellent for detecting pulmonary hypertension in COPD.

[1]  Rafael Golpe,et al.  Prognostic Value of Walk Distance, Work, Oxygen Saturation, and Dyspnea During 6-Minute Walk Test in COPD Patients , 2013, Respiratory Care.

[2]  D. Kaminsky,et al.  How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest? , 2015, Chest.

[3]  N. Adair,et al.  Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. , 2001, Archives of internal medicine.

[4]  N. Cecins,et al.  Six‐minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease , 2011, Internal medicine journal.

[5]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[6]  S. Siegelman,et al.  Pulmonary Artery Measurements in Pulmonary Hypertension: The Role of Computed Tomography , 2013, Journal of thoracic imaging.

[7]  Meilan K. Han,et al.  Pulmonary arterial enlargement and acute exacerbations of COPD. , 2012, The New England journal of medicine.

[8]  J. Wells,et al.  Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD , 2013, International Journal of COPD.

[9]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[10]  E. Wouters,et al.  Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia , 2014, Respiratory Physiology & Neurobiology.

[11]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[12]  J. Barberà Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension , 2013, Pulmonary circulation.

[13]  Jae Seung Lee,et al.  Exertional Desaturation as a Predictor of Rapid Lung Function Decline in COPD , 2012, Respiration.

[14]  A. Chaouat,et al.  Severe pulmonary hypertension and chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[15]  R. Naeije,et al.  Pulmonary hypertension in COPD , 2008, European Respiratory Journal.

[16]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[17]  G. Snider Nosology for our day: its application to chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[18]  A. Chaouat,et al.  Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. , 2010, Chest.

[19]  E. Russi,et al.  Prevalence and Prediction of Exercise-Induced Oxygen Desaturation in Patients with Chronic Obstructive Pulmonary Disease , 2012, Respiration.

[20]  J. Wells,et al.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. , 2014, Chest.

[21]  Meilan K. Han,et al.  Clinical and Radiologic Disease in Smokers With Normal Spirometry. , 2015, JAMA internal medicine.

[22]  L. Edwards,et al.  Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. , 2010, Respiratory medicine.

[23]  J. Mezey,et al.  Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity , 2015, European Respiratory Journal.

[24]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[25]  T. Welte,et al.  Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. , 2014, Chest.

[26]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[27]  B. Celli,et al.  Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. , 2015, Respiratory Medicine.

[28]  B. Make,et al.  Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. , 2010, Chest.

[29]  Ciro Casanova,et al.  Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. , 2008, Chest.

[30]  A. Chaouat,et al.  "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[31]  G. Diette,et al.  Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.

[32]  F. Laurent,et al.  Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. , 2015, American journal of respiratory and critical care medicine.

[33]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.